Everett Cunningham - 11 Oct 2022 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Reporting relationship: Chief Commercial Officer
Issuer ticker: EXAS
Reported as of: 11 Oct 2022
Net transaction value: -$504,621
SEC form: 4
Accepted by SEC: 13 Oct 2022, 20:57:44 UTC
Prior SEC filing: 01 Mar 2022
Next SEC filing: 19 Dec 2022
Source filing: View source filing
Reporting owner signature: /s/ Everett Cunningham by Mark R. Busch, attorney-in-fact

Key filing fact

Everett Cunningham filed Form 4 for EXACT SCIENCES CORP (EXAS) on 13 Oct 2022.

Key facts

This page summarizes Everett Cunningham's Form 4 filing for EXACT SCIENCES CORP (EXAS).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 13 Oct 2022, 20:57.

Change

Previous filing in this sequence was filed on 01 Mar 2022.
Current net transaction value: -$504,621.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXAS transaction

Common Stock

Award

Transaction value: $24,653
Shares: +520
Change %
Price: $47.41
Shares after: 520
Date: 02 May 2022
Ownership: Direct
Footnotes: F1

EXAS transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +20,003
Change %: +3847%
Price: $0.000000
Shares after: 20,523
Date: 11 Oct 2022
Ownership: Direct
Footnotes: F2

EXAS transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +15,003
Change %: +73%
Price: $0.000000
Shares after: 35,526
Date: 11 Oct 2022
Ownership: Direct
Footnotes: F2

EXAS transaction

Common Stock

Sale

Transaction value: $529,275
Shares: -16,872
Change %: -47%
Price: $31.37
Shares after: 18,654
Date: 12 Oct 2022
Ownership: Direct
Footnotes: F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXAS transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -20,003
Change %: -33%
Price: $0.000000
Shares after: 40,007
Date: 11 Oct 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,003
Exercise price
Footnotes: F5, F6

EXAS transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -15,003
Change %: -50%
Price: $0.000000
Shares after: 15,002
Date: 11 Oct 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,003
Exercise price
Footnotes: F5, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Represents shares of common stock purchased through Employee Stock Purchase Plan.

Footnote F2

Represents shares of common stock received upon vesting of a restricted stock unit award.

Footnote F3

Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on October 11, 2022.

Footnote F4

In addition to the shares of Common Stock reported on this Form 4, which total 18,654 shares, Mr. Cunningham also holds, in the aggregate, an additional 85,720 restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.

Footnote F5

Each restricted stock unit represents a contingent right to receive one share of common stock.

Footnote F6

Represents a restricted stock unit award that partially vested on October 11, 2022. The restricted stock units vest in three equal annual installments beginning on October 11, 2022.

Footnote F7

Represents a restricted stock unit award that vests in three annual installments, with 50% vesting on October 11, 2022, 25% vesting on October 11, 2023, and 25% vesting on October 11, 2024.